Table I.
Demographics, anaphylaxis history, and outcomes for patients with a high-risk allergy history
| Characteristic | Total N (% total) or median [IQR] |
|---|---|
| Total no. of patients | 31 |
| Age (n = 28, with n = 3 missing) | 40 [30, 53] |
| Sex | |
| Female | 22 (71) |
| Male | 6 (19) |
| Unknown | 3 (10) |
| Anaphylaxis history | |
| Injectable medication | 14 |
| PEG or PS containing | 1 |
| Subsequent PEG or PS tolerance | 1 |
| Vaccine | 8 |
| PEG or PS containing | 7 |
| Subsequent PEG or PS tolerance | 6 |
| Oral PEG3350 | 0 |
| Subsequent PEG or PS tolerance | N/A |
| Unknown cause (idiopathic) | 9 |
| Subsequent PEG or PS tolerance | 7 |
| On-Call Allergy recommendation | |
| Proceed with vaccination | 28 (90) |
| Tolerated vaccination | 28/28 |
| Do not vaccinate and refer to Allergy Clinic | 3 (10) |
| Drug Allergy Clinic assessment outcome | |
| Proceed with vaccination after consultation | 3 |
| Vaccine administered at Allergy Clinic | 1 |
| Tolerated vaccination | 1/1 |
| Vaccine administered at Occupational Health site | 2 |
| Tolerated vaccination | 2/2 |
IQR, Interquartile range; N/A, not available; PEG, polyethylene glycol; PS, polysorbate.